10 Million People Started Trading Last Year – Here’s What to Do Next
How do you make money trading?
What are the secrets pros use to beat the market day after day?
Former Chicago Board Options Exchange trader reveals all the insider tricks...
Get the Full Report Now (No Credit Card Required... Limited Time Only)
pixel

CMPI Insider Trading (Checkmate Pharmaceuticals)

Insider Ownership Percentage: 62.60%
Insider Buying (Last 12 Months): $203,202.07
Insider Selling (Last 12 Months): $0.00

Checkmate Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Checkmate Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Checkmate Pharmaceuticals Share Price & Price History

Current Price: $5.02
Price Change: Price Decrease of -0.04 (-0.79%)
As of 07/30/2021 01:00 AM ET

This chart shows the closing price history over time for CMPI up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
10 Million People Started Trading Last Year – Here’s What to Do Next
How do you make money trading?
What are the secrets pros use to beat the market day after day?
Former Chicago Board Options Exchange trader reveals all the insider tricks...
Get the Full Report Now (No Credit Card Required... Limited Time Only)
pixel

Checkmate Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/18/2021Arthur M. KriegInsiderBuy7,224$6.04$43,632.96815,734View SEC Filing Icon  
3/25/2021Arthur M. KriegInsiderBuy10,036$12.35$123,944.60743,227View SEC Filing Icon  
1/27/2021Arthur M. KriegInsiderBuy1,701$13.05$22,198.05733,191View SEC Filing Icon  
1/19/2021Arthur M. KriegInsiderBuy500$13.09$6,545.00731,490View SEC Filing Icon  
12/29/2020Arthur M. KriegInsiderBuy443$14.16$6,272.88730,990View SEC Filing Icon  
12/15/2020Arthur M. KriegInsiderBuy42$14.49$608.58720,639View SEC Filing Icon  
See Full Table
Insider Trading at Checkmate Pharmaceuticals?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Checkmate Pharmaceuticals and related companies.

SEC Filings (Institutional Ownership Changes) for Checkmate Pharmaceuticals (NASDAQ:CMPI)

77.16% of Checkmate Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CMPI by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Checkmate Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/18/2021Canada Pension Plan Investment Board10,000$0.12M0.0%-33.3%0.046%Search for SEC Filing on Google Icon
5/18/2021California State Teachers Retirement System13,503$0.16M0.0%+76.8%0.062%Search for SEC Filing on Google Icon
5/14/2021Sectoral Asset Management Inc541,766$6.58M0.5%-1.3%2.505%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp81,359$0.99M0.0%+34.0%0.376%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC103,425$1.26M0.0%+180.8%0.478%Search for SEC Filing on Google Icon
5/12/2021JPMorgan Chase & Co.25,117$0.31M0.0%+91.8%0.116%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.368,226$4.47M0.0%+49.7%1.703%Search for SEC Filing on Google Icon
5/7/2021American International Group Inc.5,217$63K0.0%+77.8%0.024%Search for SEC Filing on Google Icon
4/23/2021Strs Ohio19,300$0.23M0.0%+865.0%0.089%Search for SEC Filing on Google Icon
2/19/2021JPMorgan Chase & Co.13,092$0.19M0.0%+595.6%0.061%Search for SEC Filing on Google Icon
2/17/2021Canada Pension Plan Investment Board15,000$0.22M0.0%-50.0%0.070%Search for SEC Filing on Google Icon
2/16/2021Clough Capital Partners L P1,332,397$19.35M1.4%+1.5%6.183%Search for SEC Filing on Google Icon
2/12/2021Federated Hermes Inc.26,950$0.39M0.0%-46.1%0.125%Search for SEC Filing on Google Icon
2/11/2021Northern Trust Corp60,738$0.89M0.0%+9.2%0.282%Search for SEC Filing on Google Icon
2/9/2021Wells Fargo & Company MN2,707$39K0.0%+92.8%0.013%Search for SEC Filing on Google Icon
2/9/2021Bank of New York Mellon Corp17,436$0.25M0.0%N/A0.081%Search for SEC Filing on Google Icon
2/5/2021BlackRock Inc.245,999$3.59M0.0%-0.8%1.141%Search for SEC Filing on Google Icon
1/25/2021Strs Ohio2,000$29K0.0%+53.8%0.009%Search for SEC Filing on Google Icon
11/17/2020Clough Capital Partners L P1,313,286$14.86M1.1%N/A6.095%Search for SEC Filing on Google Icon
11/17/2020California State Teachers Retirement System7,639$88K0.0%N/A0.035%Search for SEC Filing on Google Icon
11/13/2020Sofinnova Investments Inc.3,606,707$41.51M3.1%N/A16.739%Search for SEC Filing on Google Icon
11/12/2020Federated Hermes Inc.50,000$0.58M0.0%N/A0.232%Search for SEC Filing on Google Icon
11/10/2020State Street Corp39,045$0.45M0.0%N/A0.181%Search for SEC Filing on Google Icon
11/9/2020Caas Capital Management LP44,966$0.52M0.0%N/A0.209%Search for SEC Filing on Google Icon
11/6/2020BlackRock Inc.247,921$2.85M0.0%N/A1.151%Search for SEC Filing on Google Icon
11/5/2020New York State Common Retirement Fund4,658$54K0.0%N/A0.022%Search for SEC Filing on Google Icon
11/4/2020American International Group Inc.3,019$35K0.0%N/A0.014%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Checkmate Pharmaceuticals logo
Checkmate Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing novel therapeutics for the treatment of cancer. It develops CMP-001, which is in phase II clinical trial in combination with pembrolizumab to treat patients with PD-1 refractory melanoma; combination with nivolumab to treat patients with PD-1 naïve neoadjuvant melanoma; and treatment in patients with PD-1 refractory melanoma. The company has strategic alliances with Merck KGaA and Pfizer. Checkmate Pharmaceuticals, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Read More on Checkmate Pharmaceuticals

Today's Range

Now: $5.02
Low: $5.02
High: $5.18

50 Day Range

MA: $6.01
Low: $5.02
High: $6.91

52 Week Range

Now: $5.02
Low: $5.00
High: $23.10

Volume

28,828 shs

Average Volume

31,808 shs

Market Capitalization

$108.58 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Checkmate Pharmaceuticals?

Checkmate Pharmaceuticals' top insider shareholders include:
  1. Arthur M Krieg (Insider)
10 Million People Started Trading Last Year – Here’s What to Do Next
How do you make money trading?
What are the secrets pros use to beat the market day after day?
Former Chicago Board Options Exchange trader reveals all the insider tricks...
Get the Full Report Now (No Credit Card Required... Limited Time Only)
pixel